Search clinical trials for: In-stent Restenosis

Total 426 results

Horizons International Peripheral Group
Advanced Catheter Therapies, Inc.

Completed

The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee (COPPER-A)

Cardiovascular Disease | Peripheral Arterial Disease | Peripheral Vascular Disease

United States
Xijing Hospital

Unknown

In-stent Repair and Vessel Reaction of STEMI Patients With OCT

Percutaneous Coronary Intervention | ST-Elevation Myocardial Infarction | Optical Coherence Tomography | Drug-eluting Stents

China
Assiut University

Unknown

Outcomes of Endovascular Treatment of Superficial Femoral Artery In-stent Restenosis

Peripheral Arterial Disease

Egypt
Minneapolis Heart Institute Foundation
Minneapolis Heart Institute; Twin Cities Heart Foundation

Terminated

Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis (RADAR)

Aortic Valve Stenosis

United States
ZhuHai Cardionovum Medical Device Co., Ltd.
R&G Pharma Studies Co.,Ltd.

Completed

Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis

Coronary Restenosis

China
Chinese University of Hong Kong
Lifetech Scientific (Shenzhen) Co., Ltd.

Completed

First-in-man Study of Titanium-Nitride Coated Woven-nitinol Peripheral Arterial Stent

Peripheral Arterial Disease

Hong Kong
Biosensors Europe SA

Completed

Limus Eluted From A Durable Versus ERodable Stent Coating (LEADERS)

Coronary Disease | Coronary Stenosis

Belgium, France, Germany, Netherlands, Poland, Switzerland, United Kingdom
C. R. Bard

Completed

Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis (SFA ISR)

Restenosis | Femoral Artery Occlusion | Femoral Artery Stenosis

United States
Spectranetics Corporation

Completed

TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions

Peripheral Arterial Disease

United States
Yonsei University

Terminated

Comparison of Optical Coherence Tomographic Findings After Balloon Angioplasty With Two Different Paclitaxel-Coated Balloons for the Treatment of In-Stent Restenosis in Drug-Eluting Stents

Coronary Artery Disease

Korea, Republic of
Jane Phillips Medical Center

Withdrawn

Local Paclitaxel Delivery to Prevent Restenosis in Peripheral Arterial Disease (ResTAP)

Peripheral Arterial Disease | Restenosis
Abbott Medical Devices

Completed

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study (XV CHINA SAS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angioplasty

United States
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort B (ABSORB B)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Netherlands, Poland, France, Denmark, Australia, Switzerland, Belgium
Yonsei University

Unknown

Korean Multicenter Registry of EPIC Stent for Iliac Artery Disease: (K-EPIC Registry)

Iliac Artery Disease

Korea, Republic of
Deutsches Herzzentrum Muenchen

Completed

Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES (ISAR-DESIRE 3A)

Coronary Restenosis

Germany
Abbott Medical Devices

Completed

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels (ABSORB UK)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United Kingdom
Second Hospital of Jilin University

Unknown

DCB in de Novo Coronary Lesion

Drug-coated Balloon
European Cardiovascular Research Center

Active, not recruiting

ABSORB Bioresorbable Scaffold vs. Xience Metallic Stent for Prevention of Restenosis in Patients at High Risk of Restenosis (Compare Absorb)

Coronary Artery Lesion

Italy, Spain, Belgium, Germany, United Kingdom, France, Czechia, Poland, Netherlands
B. Braun Medical International Trading Company...

Unknown

The Safety and Efficacy of SeQuent® Please in Real World Chinese Coronary Instent Restenosis Patients

Coronary In Sentrestenosis
Balton Sp.zo.o.
American Heart of Poland

Completed

First-in-man Evaluation of a Novel, Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease (PAX-r) (PAX)

Peripheral Artery Disease | Femoropopliteal Artery Disease

Poland
RWTH Aachen University

Withdrawn

The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)

Cirrhosis of the Liver | Re-stenosis
Best Vascular, Inc.

Unknown

Retrospective Long-term Safety and Efficacy Study of the Beta-Cath(TM) 3.5F System

Coronary In-stent Restenosis

United States
Azienda Ospedaliera Città della Salute e della...
University Hospital, Zürich

Completed

veRy Thin Stents for Patients With Left mAIn or bifurcatioN in Real Life: the RAIN a Multicenter Study (RAIN)

Left Main Coronary Artery Disease | Stent Thrombosis | Stent Restenosis | Coronary Bifurcations | Very Thin Stents

Italy
National Taiwan University Hospital Hsin-Chu Branch

Completed

Ascorbic Acid on Restenosis of Dysfunctional Hemodialysis Vascular Access

Hemodialysis Access Failure
Yonsei University

Unknown

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)

Symptomatic Peripheral Artery Disease With Femoropopliteal Lesions | Moderate or Severe Claudication (Rutherford Category 2 or 3) | Critical Limb Ischemia (Rutherford Category 4 or 5)

Korea, Republic of
Second Affiliated Hospital, School of Medicine,...
Ningbo No. 1 Hospital

Unknown

FrActional Flow Reserve Guided Drug Coated Balloon Only Strategy in De Novo coronarY Lesions (FADDY) (FADDY)

Coronary Stenosis

China
SIS Medical AG

Suspended

Absorb BVS vs. Drug Coated Balloon for Treatment Of ISR (AbsorbISR)

Coronary Artery Disease | Coronary Restenosis

Switzerland
Mercator MedSystems, Inc.

Completed

Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease (DANCE)

Peripheral Arterial Diseases

United States
Ain Shams University

Unknown

Use of Propranolol Hydrochloride in the Treatment of Metastatic STS

Malignant Soft Tissue Sarcoma
Abbott Medical Devices

Completed

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angina

Japan
Abbott Medical Devices

Completed

ABSORB EXTEND Clinical Investigation (ABSORB EXTEND)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Cardiovascular Disease | Coronary Restenosis | Coronary Artery Stenosis

Netherlands, Taiwan, China, New Zealand, Singapore, France, United Kingdom, Austria, Israel, Italy, Malaysia, India, Poland, Sweden, Spain, South Africa, Canada, Australia, Japan, Argentina, Brazil, Switzerland, Belgium, Denmark, Germany
Jeil Pharmaceutical Co., Ltd.

Completed

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

Hypertension With Dyslipidemia

Korea, Republic of
Dankook University

Unknown

Matrix Metalloproteinases Expression in the Neointimal Hyperplasia Induced by Drug Eluting Stent (DES) Implantation

Coronary Artery Disease | Stent Restenosis
National Taiwan University Hospital Hsin-Chu Branch

Unknown

DCB for Dialysis Access Stent Graft Restenosis

Hemodialysis Access Failure (Disorder) | Stent-Graft Restenosis | Arteriovenous Graft | Drug-coated Balloon

Taiwan
iVascular S.L.U.

Completed

Luminor Registry: Registry of the Results of Angioplasty With Drug-eluting Balloon (Paclitaxel) in the Treatment of Infrainguinal Occlusive Lesions and Restenosis From Prior Endovascular Procedures in This Sector.

Peripheral Vascular Disease

Spain
Medtronic Vascular

Completed

RESOLUTE China RCT (R-China RCT)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
National University of Ireland, Galway, Ireland
University Hospital of Limerick; University College Hospital Galway

Suspended

Effects of Remote Ischemic Preconditioning on Restenosis Post Lower Limb Revascularization Angioplasty

Peripheral Vascular Diseases

Ireland
Southeast Renal Research Institute
Dialysis Clinic, Inc.

Unknown

Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis

Arteriovenous Fistula Occlusion

United States
Centre Hospitalier Universitaire, Amiens

Withdrawn

Search for Restenosis Markers in Lower Limb Arteritis (FEMIA)

Restenosis | Lower Limb Arteritis

France
Helsinki University Central Hospital

Completed

Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae) (DRECOREST2)

Vascular Access Complication | Restenosis, Vascular Graft | Dialysis Related Complications
Medtronic Vascular

Completed

Bare Metal Bifurcation Stent Clinical Trial in Humans (BRANCH)

Myocardial Ischemia | Coronary Artery Disease

New Zealand
Rutgers, The State University of New Jersey
University of Alabama at Birmingham; National Institute of Neurological Disorders...

Completed

Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)

Myocardial Infarction | Stroke | Atherosclerosis | Carotid Stenosis | Cerebral Infarction

United States, Canada
Prof. Dr. med. Gunnar Tepe
InnoRa GmbH

Unknown

Local Paclitaxel or Balloon Angioplasty Below the Knee (SAMBA)

Restenosis | Occlusion | Stenosis

Germany, Austria
The Cleveland Clinic

Completed

Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal

Coronary Restenosis

United States
Mitsui Memorial Hospital
Teikyo University; Tokai University

Unknown

Effect of Combination of Non-sLip Element Balloon (NSE) and druG-coated bAlloon (DCB) for In-steNT Restenosis Lesions (ELEGANT)

Coronary Restenosis

Japan
Seung-Jung Park
CardioVascular Research Foundation, Korea

Terminated

Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis (RESTORE)

Coronary Restenosis

Korea, Republic of
Thorax Centrum Twente

Unknown

DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity (DUTCHPEERS)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands
Thorax Centrum Twente

Unknown

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands, Israel, Belgium
Helsinki University Central Hospital

Completed

Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study (DRECOREST1)

Peripheral Artery Occlusive Disease | Peripheral Artery Stenosis | Peripheral Artery Restenosis

Finland
C. R. Bard

Completed

FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis (RESCUE)

Restenosis

United States

Search clinical trials for: In-stent Restenosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations